United States - English - NLM (National Library of Medicine)

dpi, llc - chloroxylenol (unii: 0f32u78v2q) (chloroxylenol - unii:0f32u78v2q) - antiseptic healthcare personnel hand wash if irritation or rash occurs.

United States - English - NLM (National Library of Medicine)

guangdong boxi high-tech co.,ltd. - chloroxylenol (unii: 0f32u78v2q) (chloroxylenol - unii:0f32u78v2q), alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antimicrobial hand sanitizer to help reduce bacteria on skin

United States - English - NLM (National Library of Medicine)

shera heman zhejiang biotechnologies co.,ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic non-wash disinfectant, non-wash sanitiser gel to help reduce bacteria that potentially can cause disease. for use when soap and water are not available. - in children less than 2 months of age - on open skin wounds stop use and ask a doctor if irritation or rash occurs. these may be signs of a serious condition.

Israel - English - Ministry of Health

astellas pharma international b.v., israel - enfortumab vedotin - powder for concentrate for solution for infusion - enfortumab vedotin 20 mg/vial - enfortumab vedotin - padcev is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer (muc) who: - have previously received a programmed death receptor-1 (pd-1) or programmed death-ligand 1 (pd-l1) inhibitor, and a platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic setting or:- are ineligible for cisplatin-containing chemotherapy and have previously received a pd-1/pd-l1 inhibitor.

Israel - English - Ministry of Health

astellas pharma international b.v., israel - enfortumab vedotin - powder for concentrate for solution for infusion - enfortumab vedotin 30 mg/vial - enfortumab vedotin - padcev is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer (muc) who: - have previously received a programmed death receptor-1 (pd-1) or programmed death-ligand 1 (pd-l1) inhibitor, and a platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic setting or:- are ineligible for cisplatin-containing chemotherapy and have previously received a pd-1/pd-l1 inhibitor.

United States - English - NLM (National Library of Medicine)

prugen, inc. - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 70 mg in 1 ml - indications and usage: prtm benzoyl peroxide wash is indicated for the topical treatment of acne vulgaris. contraindications: prtm benzoyl peroxide wash is contraindicated in persons with a known hypersensitivity to any of its ingredients.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

scan tanzania company limited, tanzania - wash bottles ldpe 500 ml -

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

scan tanzania company limited, tanzania - wash bottles ldpf 250 ml -

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

scan tanzania company limited, tanzania - wash bottles ldpe 500 ml -

United States - English - NLM (National Library of Medicine)

global equipment company - water (unii: 059qf0ko0r) (water - unii:059qf0ko0r) - eyewash for cleansing the eye to help relieve irritation or burning by removing loose foreign material - continued redness or irritation of the eye - condition worsens or persists - eye pain - changes in vision